Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000769734-26-000057·COLLEGIUM PHARMACEUTICAL, INC
Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common stock, par value $0.001 per share · CUSIP: 19459J104
Event date: 2026-09-30
- Filing-level shares
- 1,514,310
- Percent of class
- 4.7%
- PRINCIPAL GLOBAL INVESTORS
Shares: 1,514,310 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769734-26-000057
- Form type
- SCHEDULE 13G/A
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Oct 29, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership